Cargando…
1237. Robust Adjuvant Activity and Dose-sparing Potential of the Novel Semisynthetic Saponin Adjuvant TQL1055 for Seasonal and Pandemic Influenza
BACKGROUND: Vaccination against both seasonal and pandemic influenza requires effective adjuvants to maximize the utility of limited antigen and to enhance immunogenicity in hyporesponsive at-risk populations. First-generation natural saponins are potent immuno-enhancers but are reactogenic and have...
Autores principales: | Buzz, Chloe, Farris, Eric, Bennett, Sean R, Frenchick, Pat, Martin, Tyler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776768/ http://dx.doi.org/10.1093/ofid/ofaa439.1422 |
Ejemplares similares
-
1238. The Novel Semisynthetic Saponin Adjuvant TQL1055 Enhances the Antibody Response to Pertussis Vaccine with an Improved Tolerability Profile over QS-21
por: Buzz, Chloe, et al.
Publicado: (2020) -
1045. Safety of the Synthetic Saponin Adjuvant TQL1055: Preliminary Results from a First-in-humans Trial
por: Bennett, Sean R, et al.
Publicado: (2021) -
Quality Assurance: from quality control to TQM/TQL
por: CERN. Geneva. Audiovisual Unit
Publicado: (2000) -
Natural and Synthetic Saponins as Vaccine Adjuvants
por: Wang, Pengfei
Publicado: (2021) -
Potentials of saponins-based adjuvants for nasal vaccines
por: Chen, Kai, et al.
Publicado: (2023)